96 related articles for article (PubMed ID: 9926251)
1. Molecular basis of targeted chemotherapy: novel concepts with special reference to the treatment of Hodgkin's disease.
Grunicke HH
Ann Oncol; 1998; 9 Suppl 5():S125-8. PubMed ID: 9926251
[TBL] [Abstract][Full Text] [Related]
2. Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.
Carbone A; Gloghini A; Castagna L; Santoro A; Carlo-Stella C
J Pathol; 2015 Sep; 237(1):4-13. PubMed ID: 25953622
[TBL] [Abstract][Full Text] [Related]
3. Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.
Carlo-Stella C; Santoro A
Biomark Med; 2015; 9(8):807-17. PubMed ID: 26223461
[TBL] [Abstract][Full Text] [Related]
4. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.
Bräuninger A; Schmitz R; Bechtel D; Renné C; Hansmann ML; Küppers R
Int J Cancer; 2006 Apr; 118(8):1853-61. PubMed ID: 16385563
[TBL] [Abstract][Full Text] [Related]
6. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Ansell SM; Lesokhin AM; Borrello I; Halwani A; Scott EC; Gutierrez M; Schuster SJ; Millenson MM; Cattry D; Freeman GJ; Rodig SJ; Chapuy B; Ligon AH; Zhu L; Grosso JF; Kim SY; Timmerman JM; Shipp MA; Armand P
N Engl J Med; 2015 Jan; 372(4):311-9. PubMed ID: 25482239
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal abnormalities in patients with Hodgkin's disease: evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells.
Poppema S; Kaleta J; Hepperle B
J Natl Cancer Inst; 1992 Dec; 84(23):1789-93. PubMed ID: 1433367
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint inhibitors in Hodgkin's lymphoma.
Jezeršek Novaković B
Eur J Haematol; 2016 Apr; 96(4):335-43. PubMed ID: 26560962
[TBL] [Abstract][Full Text] [Related]
10. Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
Greaves WO; Bueso-Ramos C; Fayad L
J Clin Oncol; 2011 Feb; 29(4):e76-8. PubMed ID: 21041711
[No Abstract] [Full Text] [Related]
11. Reed-Sternberg cell: survival in a hostile sea.
Cossman J; Messineo C; Bagg A
Lab Invest; 1998 Mar; 78(3):229-35. PubMed ID: 9520936
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
13. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
[TBL] [Abstract][Full Text] [Related]
14. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
15. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
16. Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease.
Louie DC; Kant JA; Brooks JJ; Reed JC
Am J Pathol; 1991 Dec; 139(6):1231-7. PubMed ID: 1750500
[TBL] [Abstract][Full Text] [Related]
17. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells.
Jansen MP; Hopman AH; Haesevoets AM; Gennotte IA; Bot FJ; Arends JW; Ramaekers FC; Schouten HC
J Pathol; 1998 Jun; 185(2):145-52. PubMed ID: 9713340
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.
Schmid C; Pan L; Diss T; Isaacson PG
Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of Reed-Sternberg cells and variants in Hodgkin's disease.
Gupta RK; Lister TA; Bodmer JG
Ann Oncol; 1994; 5 Suppl 1():117-9. PubMed ID: 8172808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]